| Literature DB >> 19463633 |
Kaj-Erik Klaaborg1, Henrik Egeblad, Carl-Johan Jakobsen, Kim Terp, Christian Lindskov, Henning Rud Andersen, Leif Thuesen.
Abstract
Transcatheter transapical or transfemoral aortic valve replacement has emerged as an alternative therapy of severe, symptomatic valvular aortic stenosis in surgically nonamenable patients. We report a transapical treatment of a severely stenosed 21-mm aortic Mitroflow valve bioprosthesis (Sorin Group, Vancouver, British Columbia, Canada) in an 82-year-old woman using a 23-mm Edwards SAPIEN Transcatheter Heart Valve (Edwards Lifesciences, Irvine, CA).Entities:
Mesh：
Year: 2009 PMID： 19463633 DOI： 10.1016/j.athoracsur.2008.11.034
Source DB: PubMed Journal: Ann Thorac Surg ISSN： 0003-4975 Impact factor: 4.330